UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The seattle heart failure model : Prediction of survival in heart failure

Circulation (New York, N.Y.), 2006-03, Vol.113 (11), p.1424-1433

2006

Volltextzugriff (PDF)

Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

NPJ primary care respiratory medicine, 2014-05, Vol.24 (1), p.14003, Article 14003

2014

Volltextzugriff (PDF)

Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture: A Network Meta-Analysis

Value in health, 2014-06, Vol.17 (4), p.424-432

2014

Volltextzugriff (PDF)

Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study

The American heart journal, 2012-04, Vol.163 (4), p.735-740

2012

Volltextzugriff (PDF)

A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax

Clinical and Vaccine Immunology, 2008-02, Vol.15 (2), p.314-319

2008

Volltextzugriff (PDF)

Comparison of the Levels of Immunogenicity and Safety of Zostavax in Adults 50 to 59 Years Old and in Adults 60 Years Old or Older

Clinical and Vaccine Immunology, 2009-05, Vol.16 (5), p.646-652

2009

Volltextzugriff (PDF)

Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial

Journal of Korean Medical Science, 2013, 28(12), 183, pp.1741-1748

2013

Volltextzugriff (PDF)

The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study

The journal of clinical hypertension (Greenwich, Conn.), 2009-01, Vol.11 (1), p.22-30

2009

Volltextzugriff (PDF)

Bayesian sequential probability ratio test for vaccine efficacy trials

Computational statistics, 2024-02

2024

Volltextzugriff (PDF)

FERTILITY INTENTIONS: ARE THE UNDECIDED MORE LIKE THOSE WHO WANT MORE OR WANT NO MORE CHILDREN?

Journal of biosocial science, 2007-01, Vol.39 (1), p.137-145

2007

Volltextzugriff (PDF)

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

Breast cancer research and treatment, 2018-08, Vol.170 (3), p.535-545

2018

Volltextzugriff (PDF)

Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers

The American journal of cardiology, 2004-09, Vol.94 (5), p.632-636

2004

Volltextzugriff (PDF)

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial

Breast cancer research and treatment, 2018-02, Vol.167 (3), p.659-669

2018

Volltextzugriff (PDF)

A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment

Clinical pharmacology and therapeutics, 2021-02, Vol.109 (2), p.403-415

2021

Volltextzugriff (PDF)

Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats

Toxicologic pathology, 2024-02, Vol.52 (2-3), p.88-98

2024

Volltextzugriff (PDF)

A goodness-of-fit test for overdispersed binomial (or multinomial) models

Journal of statistical planning and inference, 2008-05, Vol.138 (5), p.1459-1471

2008

Volltextzugriff (PDF)

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Breast cancer research and treatment, 2018-06, Vol.169 (3), p.469-479

2018

Volltextzugriff (PDF)

Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial

Current medical research and opinion, 2013-06, Vol.29 (6), p.589-596

2013

Volltextzugriff (PDF)

Health-related quality of life of postmenopausal women with hormone receptor–positive, HER2- advanced breast cancer treated with ribociclib + letrozole: Results from MONALEESA-2

Journal of clinical oncology, 2017-11, Vol.35 (31_suppl), p.133-133

2017

Volltextzugriff (PDF)

Health-related quality of life (HRQoL) of postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) treated with ribociclib + letrozole: Results from MONALEESA-2

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.1020-1020

2017

Volltextzugriff (PDF)

The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis

Bone (New York, N.Y.), 2015-08, Vol.77, p.115-119

2015

Volltextzugriff (PDF)

ON CLASSIFICATION OF A BIVARIATE BINARY OBSERVATION

Communications in statistics. Theory and methods, 2001-01, Vol.30 (11), p.2259-2279

2001

Volltextzugriff (PDF)

Erratum to “First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results” [Breast 36 (Suppl. 1) (November 2017) S44–S45]

Breast (Edinburgh), 2018-08, Vol.40, p.53-53

2018

Volltextzugriff (PDF)

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial

Current medical research and opinion, 2011-04, Vol.27 (4), p.821-833

2011

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(43)

Publikationsform

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(26)
Life Sciences & Biomedicine
(26)
Female
(24)
Middle Aged
(21)
Male
(19)
Aged
(17)
Adult
(10)
General & Internal Medicine
(10)
Treatment Outcome
(10)
Drug Combinations
(9)
Risk Factors
(9)
Aged, 80 And Over
(8)
Biological And Medical Sciences
(8)
Hypertension
(8)
Hypertension - Drug Therapy
(8)
Medical Sciences
(8)
Medicine, General & Internal
(8)
Amlodipine - Administration & Dosage
(7)
Heptanoic Acids - Administration & Dosage
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Activity and safety of ceritinib in patients with ALK -rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial

The seattle heart failure model : Prediction of survival in heart failure

Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial

Bazedoxifene versus Oral Bisphosphonates for the Prevention of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis at Higher Risk of Fracture: A Network Meta-Analysis

Relationship of antihypertensive treatment to plasma markers of vascular inflammation and remodeling in the Comparison of Amlodipine versus Enalapril to Limit Occurrences of Thrombosis study

A Double-Blind, Randomized, Controlled, Multicenter Safety and Immunogenicity Study of a Refrigerator-Stable Formulation of Zostavax

Comparison of the Levels of Immunogenicity and Safety of Zostavax in Adults 50 to 59 Years Old and in Adults 60 Years Old or Older

Proactive multifactorial intervention strategy reduces the risk of cardiovascular disease estimated with region-specific risk assessment models in Pacific Asian patients participating in the CRUCIAL trial

The Use of a Single‐Pill Calcium Channel Blocker/Statin Combination in the Management of Hypertension and Dyslipidemia: A Randomized, Placebo‐Controlled, Multicenter Study

Bayesian sequential probability ratio test for vaccine efficacy trials

FERTILITY INTENTIONS: ARE THE UNDECIDED MORE LIKE THOSE WHO WANT MORE OR WANT NO MORE CHILDREN?

Health-related quality of life of postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer treated with ribociclib + letrozole: results from MONALEESA-2

Comparison of mortality rates after acute myocardial infarction in smokers versus nonsmokers

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial

A Microdose Cocktail to Evaluate Drug Interactions in Patients with Renal Impairment

Magnitude of Urine Albumin and KIM-1 Changes Can be Used to Differentiate Glomerular Injury From Tubular Injury in Rats

A goodness-of-fit test for overdispersed binomial (or multinomial) models

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Post hoc analysis of the Cluster Randomized Usual Care versus Caduet Investigation Assessing Long-term risk (CRUCIAL) trial

Health-related quality of life of postmenopausal women with hormone receptor–positive, HER2- advanced breast cancer treated with ribociclib + letrozole: Results from MONALEESA-2

Health-related quality of life (HRQoL) of postmenopausal women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC) treated with ribociclib + letrozole: Results from MONALEESA-2

The effects of bazedoxifene on bone structural strength evaluated by hip structure analysis

ON CLASSIFICATION OF A BIVARIATE BINARY OBSERVATION

Erratum to “First-line ribociclib plus letrozole for postmenopausal women with HR+, HER2- ABC: MONALEESA-2 safety results” [Breast 36 (Suppl. 1) (November 2017) S44–S45]

Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial

Suchergebnisse filtern